The Hedgehog (HH)/Glioma-associated Oncogene Homolog (GLI) signaling pathway that plays a role in chemotherapy resistance and cellular self-renewal is supposed to be a novel therapeutic target in AML [17]. The gene discussed is GLI1; the disease is acute myeloid leukemia.